Clinical Trial Update: PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM) [Phase 3]

View source ↗

Summary

Phase 3 trial PRO-122LATAM assessing PRO-122 versus concomitant therapy in uncontrolled primary open-angle glaucoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• PRO-122

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Primary Open-angle Glaucoma | Phase 3 | Status: TERMINATED